CESCA THERAPEUTICS INC. 4
4 · CESCA THERAPEUTICS INC. · Filed May 16, 2017
Insider Transaction Report
Form 4
Westgate Mark
Director
Transactions
- Award
Stock Options
2017-05-10$3.19/sh+13,500$43,065→ 13,500 totalExercise: $3.19Exp: 2027-05-10→ Common Stock (13,500 underlying)
Footnotes (1)
- [F1]The option vests as to 562 shares on the date of grant, 562 shares on the last day of each month thereafter for 22 months (beginning on June 30, 2017) and 574 shares on April 30, 2019, subject to the early termination provisions and other terms and conditions of the 2016 Equity Incentive Plan, as amended.